Cadre Holdings, Inc. (CDRE) Stock

Cadre Holdings, Inc. (CDRE) is a Healthcare stock trading at $28.24 (as of 2026-06-18), with a market capitalization of $1.33B and a trailing P/E of 36.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies. The company was founded in 1964 and is headquartered in Jacksonville, Florida.

Valuation — source: SEC EDGAR (first-party)
Price$28.24
Market Cap$1.33B
P/E Ratio36.3
EV / EBITDA19.9
Price / Book3.88
Price / Sales2.05
Dividend Yield1.2%
DCF Value (model)$24.65
DCF Upside vs Price-12.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$610.31M
Net Margin7.2%
Return on Equity11.0%
Debt / Equity1.09
Current Ratio2.26
Revenue Growth (YoY)7.5%
EPS Growth (YoY)20.0%
FCF Growth (YoY)117.7%
Financial Health — source: SEC EDGAR
Altman Z-Score3.15 (safe)
Piotroski F-Score6/9 (moderate)
Valuation vs Sector & Industry
Stock P/E36.3
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector73.0%
vs Industry14.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFMR LLC ($101.83M)
Institutional Holders Tracked10
Congressional Trades (recent)6
Company
SectorHealthcare
IndustryMedical Equipment
CEOWarren Kanders
Employees2,284
CountryUS
IPO Date2021-11-04

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • National Vision Holdings, Inc. (EYE)
  • AtriCure, Inc. (ATRC)
  • LeMaitre Vascular, Inc. (LMAT)
  • PROCEPT BioRobotics Corporation (PRCT)
  • AxoGen, Inc. (AXGN)
  • Enovis Corporation (ENOV)
  • EyePoint Pharmaceuticals, Inc. (EYPT)
  • NovoCure Limited (NVCR)
CDRE earnings history · CDRE institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.